India & Merck Group

India: India is identified as a key country driving growth in the Asia Pacific Air Quality Monitoring Systems Market due to its fast pace of industrialization and urbanization.

Merck Group: Merck Group is mentioned as a top company in the Air Quality Monitoring Systems Market, indicating its participation in a growing sector.

India: India is the beneficiary of the Semicon 2.0 programme, which aims to position the country as a global semiconductor hub and reduce import dependence.

Merck Group: Signed an MoU with Tata Group to support semiconductor ecosystem development in India.

India: Merck plans to allow Indian manufacturers to produce generic alimatravir, potentially expanding access.

Merck Group: Announced plans to allow generic production of alimatravir, potentially expanding market access.

India: India is a potential market, with media coverage and potential patient impact.

Merck Group: Merck co-developed the vaccine and provided Pembrolizumab, the combination partner. Its shares rose about 10-12%, and the success helps Merck prepare for Pembrolizumab's patent expiration by expanding its cancer portfolio.

India: Home to Serum Institute of India, manufacturing vaccine doses. Its role is in vaccine production.

Merck Group: Manufacturer of RVSV-ZEBOV vaccine, which is being considered for cross-protection trials. Its vaccine could play a role in the response, benefiting its reputation.